CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
Australian investors had some respite on Friday, as volatility disappeared and the S&P/ASX 200 (ASX: XJO) gained 2.2% to finish the week.
I think that investing in ASX shares is the best thing people can do to grow their wealth. An emergency fund can help investors invest better.
The S&P/ASX 200 (ASX: XJO) didn’t follow global markets higher on Thursday as CSL (ASX:CSL) and Woodside (ASX:WPL) shares made headlines.
The S&P/ASX 200 (ASX:XJO) dropped 0.7% on Thursday as Wesfarmers (ASX:WES) and Corporate Travel (ASX:CTD) shares make headlines.
The S&P/ASX 200 (ASX: XJO) finished broadly flat on Tuesday as Woolworths (ASX:WOW) and Mesoblast (ASX:MSB) shares were in the news.
CSL Limited (ASX: CSL) has announced a blockbuster US$12.3 billion (AU$17.2 billion) tender offer for Vifor Pharma after trading hours today.
The S&P/ASX 200 (ASX: XJO) managed another strong opening on Monday as Charter Hall (ASX:CHC) and Ramsay (ASX:RHC) shares made headlines.
Is the Washington H. Soul Pattinson and Co. Ltd (ASX:SOL) share price good value after its annual general meeting (AGM)?
The S&P/ASX 200 (INDEXASX:XJO) managed to eke out a tiny gain on Monday as Bapcor (ASX:BAP) and BNPL shares like Zip (ASX:Z1P) made headlines.
